## NDAQ: Nasdaq, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.39 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($86.80)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Nasdaq Tells Trump Crypto Partner Alt5 Sigma It ‘No Longer Meets’ Listing Requirements After Missed Report**
- Source: MSN | 20251206T230946 | Neutral | Relevance: 81%
- Nasdaq informed Alt5 Sigma, a partner to Donald Trump's crypto venture, that it no longer meets listing requirements due to failure to file its quarterly report. The company has until December 10 to submit a plan for regaining compliance. This warning comes as Alt5 Sigma is in a partnership to launch the "TrumpCoin" altcoin.

**2. Form 424B2 GOLDMAN SACHS GROUP INC**
- Source: StreetInsider | 20251208T190913 | Neutral | Relevance: 70%
-  Goldman Sachs Group Inc. has filed Form 424B2 for Autocallable Contingent Coupon Underlier-Linked Notes. These notes are linked to the Russell 2000 Index, Nasdaq-100 Technology Sector Index, and VanEck Semiconductor ETF, offering potential monthly coupons if underlier levels meet specific thresholds. The notes are subject to automatic redemption and significant risks, including the creditworthiness of GS Finance Corp. and The Goldman Sachs Group, Inc., and potential loss of the entire investment.

**3. Basel Medical Group receives delinquency notification from Nasdaq**
- Source: MSN | 20251206T052321 | Neutral | Relevance: 65%
- Basel Medical Group announced it has received a delinquency notification from Nasdaq for failing to timely file its Form 10-Q for the quarter ended September 30, 2025. The company intends to submit a plan to regain compliance within 60 calendar days and expects to file the Form 10-Q as soon as practicable.

**4. AppLovin to Participate in the Nasdaq 53rd Investor Conference Held in Association with Morgan Stanley**
- Source: Yahoo Finance Singapore | 20251208T060239 | Neutral | Relevance: 64%
- AppLovin Corporation will participate in a fireside chat at the Nasdaq 53rd Investor Conference in London on December 9, 2025, at 10:35 a.m. GMT. A webcast of the event will be available on the Company's Investor Relations website. AppLovin is a leading marketing platform that provides end-to-end software and AI solutions for businesses.

**5. Kennedy Capital Management LLC Has $18.18 Million Stock Holdings in IES Holdings, Inc. $IESC**
- Source: MarketBeat | 20251206T090939 | Neutral | Relevance: 63%
- Kennedy Capital Management LLC significantly reduced its stake in IES Holdings, Inc. by 20.1% in Q2, now holding 61,372 shares valued at approximately $18.18 million. Despite recent insider selling activities, including the CFO and CEO selling shares, insiders still own 56.76% of the company's stock. IES Holdings reported strong Q3-like results with $3.77 EPS and $897.8 million revenue, and analysts currently rate the stock as a "Buy" with some upgrading to "strong-buy."

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Morgan Stanley | $110 | $97 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Morgan Stanley | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+6.9%)
- Investor AB: 10.2% (0.0%)
- Blackrock Inc.: 7.0% (+8.3%)
- Wellington Managemen: 7.0% (-3.5%)
- Massachusetts Financ: 4.6% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.39 suggests fair value with growth premium. Forward P/E 23.6x stretched relative to 11% growth. Quality metrics strong (margin 20%). Analyst sentiment positive (1 raises, avg +13%). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $51.5B |
| Beta | 1.02 |
| 52W Range | $64.84 - $97.63 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.39 |
| Forward P/E | 23.6 |
| Current P/E | 26.2 |
| YoY Growth | 11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. Elevated volume (1.6x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.30% (CS: 56) | Neutral |
| RSI_14 | 56.2 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.050x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $89.80
- **Stop Loss:** $86.80 (3.3% risk)
- **Target:** $95.80 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 333
- **Position Value:** $29,903.40
- **Portfolio %:** 29.90%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-28 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.88 | +3.7% |
| 2025Q2 | $0.81 | $0.85 | +4.6% |
| 2025Q1 | $0.77 | $0.79 | +2.5% |
| 2024Q4 | $0.75 | $0.76 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*